Current Opinion for Hypertension in Renal Fibrosis

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Pathophysiology

Background:

• Arterial hypertension is a global health issue linked to significant morbidity and mortality.
• Hypertension is a primary risk factor for cardiovascular diseases and a leading cause of chronic kidney disease (CKD) progression.
• Hypertensive nephropathy, characterized by renal interstitial fibrosis, is a major contributor to CKD mortality.

Purpose of the Study:

• To provide an overview of the pathophysiologic and mechanistic features of renal fibrosis in hypertension.
• To elucidate the complex mechanisms underlying hypertensive renal fibrosis.
• To identify potential therapeutic targets for halting or reversing renal fibrosis.

Main Methods:

• Review of existing literature on hypertensive nephropathy and renal fibrosis.
• Analysis of the synergistic contributions of various factors to fibrosis pathogenesis.
• Synthesis of current understanding of the mechanisms involved.

Main Results:

• Hypertension induces renal interstitial fibrosis via aberrant fibroblast activation and excessive extracellular matrix (ECM) generation.
• Proteinuria, tubular hypertrophy, oxidative stress, RAAS activation, and inflammation are key contributors to hypertensive renal fibrosis.
• The precise mechanisms of hypertensive renal fibrosis are complex and not fully understood.

Conclusions:

• Effective clinical therapies to halt or reverse renal fibrosis in hypertension are limited.
• Further research into the mechanisms of hypertensive renal fibrosis is essential for developing novel treatment strategies.
• Improved understanding will aid in screening treatments to prevent hypertension-associated renal destruction.